605 related articles for article (PubMed ID: 35794566)
1. Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora.
Sadrekarimi H; Gardanova ZR; Bakhshesh M; Ebrahimzadeh F; Yaseri AF; Thangavelu L; Hasanpoor Z; Zadeh FA; Kahrizi MS
J Transl Med; 2022 Jul; 20(1):301. PubMed ID: 35794566
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. Prebiotic effects: metabolic and health benefits.
Roberfroid M; Gibson GR; Hoyles L; McCartney AL; Rastall R; Rowland I; Wolvers D; Watzl B; Szajewska H; Stahl B; Guarner F; Respondek F; Whelan K; Coxam V; Davicco MJ; Léotoing L; Wittrant Y; Delzenne NM; Cani PD; Neyrinck AM; Meheust A
Br J Nutr; 2010 Aug; 104 Suppl 2():S1-63. PubMed ID: 20920376
[TBL] [Abstract][Full Text] [Related]
4. The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?
Smet A; Kupcinskas J; Link A; Hold GL; Bornschein J
Cell Mol Gastroenterol Hepatol; 2022; 13(3):857-874. PubMed ID: 34506954
[TBL] [Abstract][Full Text] [Related]
5. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
6. Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity.
Kunika ; Frey N; Rangrez AY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108423
[TBL] [Abstract][Full Text] [Related]
7. The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms.
Mima K; Ogino S; Nakagawa S; Sawayama H; Kinoshita K; Krashima R; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Sakamoto Y; Yamashita YI; Yoshida N; Chikamoto A; Ishiko T; Baba H
Surg Oncol; 2017 Dec; 26(4):368-376. PubMed ID: 29113654
[TBL] [Abstract][Full Text] [Related]
8. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
10. The microbiome and hepatobiliary-pancreatic cancers.
Mima K; Nakagawa S; Sawayama H; Ishimoto T; Imai K; Iwatsuki M; Hashimoto D; Baba Y; Yamashita YI; Yoshida N; Chikamoto A; Baba H
Cancer Lett; 2017 Aug; 402():9-15. PubMed ID: 28527946
[TBL] [Abstract][Full Text] [Related]
11. Gut dysbiosis and heart failure: navigating the universe within.
Madan S; Mehra MR
Eur J Heart Fail; 2020 Apr; 22(4):629-637. PubMed ID: 32168550
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights.
Jain H; Marsool MDM; Goyal A; Sulaiman SA; Fatima L; Idrees M; Sharma B; Borra V; Gupta P; Nadeem A; Jain J; Ali H; Sohail AH
Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102179. PubMed ID: 37923029
[TBL] [Abstract][Full Text] [Related]
13. [Gut microbiota and immune crosstalk in metabolic disease].
Burcelin R
Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
[TBL] [Abstract][Full Text] [Related]
14. Emerging pathogenic links between microbiota and the gut-lung axis.
Budden KF; Gellatly SL; Wood DL; Cooper MA; Morrison M; Hugenholtz P; Hansbro PM
Nat Rev Microbiol; 2017 Jan; 15(1):55-63. PubMed ID: 27694885
[TBL] [Abstract][Full Text] [Related]
15. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gut microbial β-glucuronidase effectively prevents carcinogen-induced microbial dysbiosis and intestinal tumorigenesis.
Cheng KW; Tseng CH; Chen IJ; Huang BC; Liu HJ; Ho KW; Lin WW; Chuang CH; Huang MY; Leu YL; Roffler SR; Wang JY; Chen YL; Cheng TL
Pharmacol Res; 2022 Mar; 177():106115. PubMed ID: 35124207
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of skin microbiome and gut microbiome in melanoma progression.
Mekadim C; Skalnikova HK; Cizkova J; Cizkova V; Palanova A; Horak V; Mrazek J
BMC Microbiol; 2022 Feb; 22(1):63. PubMed ID: 35216552
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Gut Microbiome in Hematological Cancers.
Hussein N; Rajasuriar R; Khan AM; Lim YA; Gan GG
Mol Cancer Res; 2024 Jan; 22(1):7-20. PubMed ID: 37906201
[TBL] [Abstract][Full Text] [Related]
19. Impact of the Gastrointestinal Tract Microbiota on Cardiovascular Health and Pathophysiology.
Gunaydin Akyildiz A; Biondi-Zoccai G; De Biase D
J Cardiovasc Pharmacol; 2022 Jul; 80(1):13-30. PubMed ID: 35384898
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
